Table 4.
Analyses of risk factors for benign paroxysmal positional vertigo in patients with anxiety disorders
| Predictive variables | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| HR (95 % CI) | P value | HR (95 % CI) | P value | |
| Age (≥60 = 1, <60 = 0) | 1.50 (1.07–2.10) | .019 | 1.13 (0.76–1.67) | .561 |
| Sex (female = 1, male = 0) | 1.74 (1.26–2.41) | .001 | 1.81 (1.31–2.50) | <.001 |
| Comorbidities | ||||
| Hypertension | 1.56 (1.14–2.12) | .005 | 1.18 (0.81–1.71) | .392 |
| Diabetes mellitus | 1.99 (1.17–3.37) | .011 | 1.47 (0.84–2.57) | .173 |
| Chronic liver diseases | 1.14 (0.84–1.57) | .403 | ||
| Autoimmune diseases | 1.16 (0.70–1.91) | .566 | ||
| Congestive heart failure | 1.55 (0.76–3.15) | .226 | ||
| Hyperlipidemia | 3.74 (1.67–8.38) | <.001 | 1.24 (0.86–1.80) | .262 |
| Nephropathy | 1.40 (0.89–2.21) | .146 | ||
| Cerebrovascular disease | 1.90 (1.29–2.80) | .001 | 1.53 (1.00–2.34) | .050 |
| COPD | 1.47 (1.06–2.04) | .021 | 1.27 (0.90–1.80) | .169 |
HR indicates hazard ratio, CI indicates confidence interval, COPD indicates chronic obstructive pulmonary disease